17 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2268282/compared-to-estimates-tds-tds-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2268282
May 03, 2024 - The headline numbers for TDS (TDS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:8801071460809054784
0
https://www.zacks.com/stock/news/2227561/telephone-data-systems-tds-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2227561
Feb 16, 2024 - TDS (TDS) delivered earnings and revenue surprises of 35.29% and 2.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:5463952516636224107
0
https://www.zacks.com/stock/news/2230242/analysts-estimate-toronto-dominion-bank-td-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2230242
Feb 22, 2024 - Toronto-Dominion (TD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-5740189925861518755
0
https://seekingalpha.com/news/4080047-td-cowen-cuts-immuneering-to-market-perform-cites-phase-1-data?source=feed_sector_healthcare
Mar 15, 2024 - TD Cowen has downgraded Immuneering (IMRX) to market perform, citing disappointing data from the company’s Phase 1 study for IMM-1-104 in treating solid tumors. Read more here.
0
sa:-7685492903346525306
0
https://www.zacks.com/stock/news/2250469/why-td-synnex-snx-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2250469
Apr 04, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:-5395712984498458982
0
https://www.zacks.com/stock/news/2268202/telephone-and-data-systems-tds-q1-earnings-beat-top-line-falls?cid=CS-ZC-FT-analyst_blog|earnings_article-2268202
May 03, 2024 - Telephone and Data Systems (TDS) reports a top-line decline year over year, owing to weakness in the U.S. Cellular segment. Healthy traction in the TDS Telecom vertical is a tailwind.
zc:391522575857495031
0
https://www.fool.com/investing/2024/05/05/3-super-safe-dividend-stocks-that-have-been-making/?source=iedfolrf0000001
May 05, 2024 - These stocks have rock-solid businesses and they have impressive track records for paying dividends.
0
fool:-4659738881227811098
0